PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1733557-0	1992	Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.	Dipyridamole	83-95	solute carrier family 25 member 1	Homo sapiens	51-54	
1733557-4	1992	The presence of DP in the washout medium also increased the incorporation of ara-C into DNA and the formation of ara-CDP-choline.	Dipyridamole	16-18	cut like homeobox 1	Homo sapiens	117-120	
1733557-5	1992	The level of ara-CDP-choline continued to increase in both DP-containing and DP-free media for the first 4 h following drug removal and the formation of ara-CDP-choline continued during the first few hours in ara-C-free medium.	Dipyridamole	59-61	cut like homeobox 1	Homo sapiens	17-20	
1733557-6	1992	At the end of the 8-h wash in DP-containing medium, the cellular concentration of ara-CDP-choline was equivalent to that found at the beginning of the washout period.	Dipyridamole	30-32	cut like homeobox 1	Homo sapiens	86-89	
1733557-7	1992	Although statistically significant, the effect of DP on ara-CTP retention in AML blasts was much less pronounced than that previously observed in L5178Y leukemia.	Dipyridamole	50-52	solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1	Mus musculus	60-63	
1733557-9	1992	The effect of DP in prolonging ara-CTP retention was proportional to the number of [3H]-NBMPR binding sites.	Dipyridamole	14-16	solute carrier family 25 member 1	Homo sapiens	35-38	
1733557-9	1992	The effect of DP in prolonging ara-CTP retention was proportional to the number of [3H]-NBMPR binding sites.	Tritium	84-86	solute carrier family 25 member 1	Homo sapiens	35-38	
1733557-9	1992	The effect of DP in prolonging ara-CTP retention was proportional to the number of [3H]-NBMPR binding sites.	4-nitrobenzylthioinosine	88-93	solute carrier family 25 member 1	Homo sapiens	35-38